stockrow
Friday 6 November 2026
Export MDLN’s income statement to Excel — free account
Medline Inc.
MDLN Healthcare Medical Instruments & Supplies
Medline Inc.’s revenue for fiscal 2025 (year ended December 2025) was $28.4 billion, up 11.5% from fiscal 2024.
- Revenue
- +14.1%
- Free cash flow
- +916.1%
- Total debt
- −23.7%
Quarter to September 2026, against a year earlier
39.71
0.05
−0.13%
Follow MDLN
Alert me
Medline Inc. (MDLN) Debt to equity
Medline Inc.'s debt to equity at the end of the quarter to 30 September 2026 was 0.6×, down 0.0× from fiscal 2025 (0.7×). That is above the Medical Instruments & Supplies industry median of 0.1× and above the Healthcare sector median of 0.0×.
Debt to equity, annual
Embed this chart
Annual newest first
| Period | Debt to equity | Change |
|---|---|---|
| FY2025 | 0.7× | (36.20%) |
| FY2024 | 1.0× | — |
| FY2023 | 0.0× | — |
Quarterly newest first
| Period | Debt to equity | Change |
|---|---|---|
| Sep 2026 | 0.6× | (1.58%) |
| Jun 2026 | 0.7× | 1.48% |
| Mar 2026 | 0.6× | (0.25%) |
| Dec 2025 | 0.7× | — |
| 4 more quarters | Free account |
Debt to equity against peers
| Company | Debt to equity |
|---|---|
| ISRG Intuitive Surgical, Inc. compare | 0.0× |
| RMD ResMed Inc. compare | 0.0× |
| WST West Pharmaceutical Services, Inc. compare | 0.1× |
| SOLV Solventum Corporation compare | 0.1× |
| ALC Alcon compare | 0.2× |
| COO The Cooper Companies, Inc. compare | 0.3× |
| BDX Becton, Dickinson and Company compare | 0.6× |
| MDLN Medline Inc. | 0.6× |
| BAX Baxter International Inc. compare | 1.3× |
| Medical Instruments & Supplies industry median | 0.1× |
| Healthcare sector median | 0.0× |
| Market median | 0.1× |
What Debt to equity is
Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.
(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)
More on MDLN
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Book value per share
- The full statement